Balance Sheet
Cash Flow Statement
Capital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeoVax Labs (GOVX) Gains from Investment Securities (2016 - 2025)

Historic Gains from Investment Securities for GeoVax Labs (GOVX) over the last 15 years, with Q3 2025 value amounting to $1.1 million.

  • GeoVax Labs' Gains from Investment Securities rose 24136.22% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.1 million, marking a year-over-year increase of 24136.22%. This contributed to the annual value of $333648.0 for FY2024, which is 14786.46% up from last year.
  • GeoVax Labs' Gains from Investment Securities amounted to $1.1 million in Q3 2025, which was up 24136.22% from $1.1 million recorded in Q2 2025.
  • GeoVax Labs' 5-year Gains from Investment Securities high stood at $2.1 million for Q1 2023, and its period low was $133648.0 during Q1 2024.
  • For the 5-year period, GeoVax Labs' Gains from Investment Securities averaged around $862013.4, with its median value being $962300.0 (2021).
  • In the last 5 years, GeoVax Labs' Gains from Investment Securities tumbled by 9350.85% in 2024 and then soared by 75219.98% in 2025.
  • Over the past 5 years, GeoVax Labs' Gains from Investment Securities (Quarter) stood at $962300.0 in 2021, then crashed by 85.73% to $137276.0 in 2022, then fell by 1.94% to $134609.0 in 2023, then soared by 147.86% to $333648.0 in 2024, then soared by 241.36% to $1.1 million in 2025.
  • Its Gains from Investment Securities was $1.1 million in Q3 2025, compared to $1.1 million in Q2 2025 and $1.1 million in Q1 2025.